News Release

Targeting Mitochondria 2023 will highlight current and future mitochondrial research in October in Berlin

Business Announcement

Mitochondria-Microbiota Task Force

World Mitochondria Society

image: World Mitochondria Society view more 

Credit: World Mitochondria Society (WMS)

The World Mitochondria Society is organizing its 14th world conference, Targeting Mitochondria 2023, on October 11-13 at the Steigenberger Hotel Am Kanzleramt, Berlin. Targeting Mitochondria 2023 will address the latest advances and perspectives in mitochondrial research and provide an outlook on future mitochondrial therapies.

Volkmar Weissig, president of the World Mitochondria Society, and Marvin Edeas, president of the scientific committee, said, "This year  we will have specific sessions on innovations such as mitochondria in space, exosome-based mitochondrial medicine, mitochondria transplantation and many other topics. Targeting Mitochondria will not only showcase the latest advances, but also highlight the latest strategies to take clinical translation to a new level."

Targeting Mitochondria 2023 Sessions

The congress will be an opportunity to learn more and exchange about:

  • Mitochondrial Biodynamics: Standpoint 2023
  • Mitochondria & Longevity: Towards Expanding Life Span
  • Novel Advances in Mitochondria Quality Assessment
  • Mitochondria & Our Changing Environment
  • Pharmaceutical & Non-Pharmaceutical Mitochondria-Based Innovations
  • Mitochondria, Microgravity & Space Travel – A glance into the future


Among WMS Annual Meeting 2023 Speakers

Defining the molecular nature of the mitochondrial permeability transition pore(s) Paolo Bernardi, the University of Padova, Italy

Protein Transport across Mitochondrial MembranesPeter Rehling, University Medical Center Göttingen, Germany

What spaceflight and bed rest have in common: A proteomic point of viewMarta Murgia, University of Padova, Italy

The Role of Mitochondria in Liver RegenerationJiri Neuzil, Griffith University, Australia

Exogenous Mitochondrial Internalization for Corneal Dystrophy TreatmentInternalization of Exogenous Mitochondria for Endothelial Corneal Dystrophy TreatmentPatrick J. Rochette, Université Laval, Canada

Mitochondrial Stress as a Central Biological Hub for Spaceflight ImpactAfshin Beheshti, NASA Ames Research Center, USA

Repairing Marginal Kidneys with Mitochondrial Transplantation: A New Powerful Tissue Engineering Tool That Will Change the Transplant LandscapeGiuseppe Orlando, Wake Forest University, USA

Mitochondria Organelle Transplantation for Neurological Diseases and AgingMark S. Kindy, University of South Florida, USA

Cardiac MitoMed: From Bench to BedsideCardiac MitoMed: From Bench to BedsideSang-Bing Ong, The Chinese University of Hong Kong, China

Restoration of Mitochondrial Homeostasis provides Glaucoma NeuroprotectionArupratan Das, Indiana University School of Medicine, USA

Personalized Medicine in Mitochondrial Health and Disease: Myth and RealityCiro Leonardo Perri, the University of Bari Aldo Moro, Italy


Innovations & Abstracts Submission

You can share your innovations and latest discoveries in front of international mitochondria experts and academics.

Among the abstracts and innovations submitted, the World Mitochondria Society will discern 4 awards at the end of Targeting Mitochondria 2023:

  • Best Scientific Communication
  • Best Short Oral Presentation
  • Best poster Presentation
  • Best Industrial Innovation related to mitochondria


About the World Mitochondria Society

The World Mitochondria Society emerged seamlessly out of a series of yearly conferences organized since 2010 by the International Society of Antioxidants in Nutrition and Health. The current president of the WMS is Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA.

Scientific committee of the World Mitochondria Society

President Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA

Founder Marvin Edeas, Institut Cochin, INSERM 1016, Université de Paris, France

Eric Barrey, INRA, France

Martin Bergö, Karolinska Instuitutet, Sweden

Laurent Chatre, CNRS, Université de Caen-Normandie, France

Carsten Culmsee, Magburg University, Germany

Frank Gellerich, Otto-von-Guericke-University, Germany

Vladimir Gogvadze, Karolinska Institutet, Sweden

Naïg Gueguen, MitoVasc Institute, Angers University Hospital Center, France

Ian Holt, Instituto de Investigación Sanitaria Biodonostia, Spain

Devika Manickam, Duquesne University, USA

James McCully, Harvard Medical School, USA

Egbert Mik, Erasmus MC, The Netherlands

Maik Hüttemann, Wayne State University School of Medicine, USA

Carole Nicco, Institut Cochin - INSERM U1016, Université Paris Descartes, France

Nicole Noren Hooten, National Institutes of Health, USA

Alessandro Prigione, Max Delbrueck Center for Molecular Medicine, Germany

Miria Ricchetti, Institut Pasteur, France

Ivan Tarassov, Labex MitoCross, France

Hans Zischka, Institute of Molecular Toxicology and Pharmacology, Germany

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.